Postma EL, Verkooijen HM, van Diest PJ, Willems SM, van den Bosch MA, van Hillegersberg R. Discrepancy between routine and expert pathologists’ assessment of non-palpable breast cancer and its impact on locoregional and systemic treatment. Eur J Pharmacol. 2013;717(1–3):31–5.
Article
Google Scholar
Chang WC, Chang CF, Li YH, Yang CY, Su RY, Lin CK, Chen YW. A histopathological evaluation and potential prognostic implications of oral squamous cell carcinoma with adverse features. Oral Oncol. 2019;95:65–73.
Article
Google Scholar
Lindenblatt Rde C, Martinez GL, Silva LE, Faria PS, Camisasca DR, Lourenco Sde Q. Oral squamous cell carcinoma grading systems—analysis of the best survival predictor. J Oral Pathol Med. 2012;41(1):34–9.
Article
Google Scholar
Padma R, Kalaivani A, Sundaresan S, Sathish P. The relationship between histological differentiation and disease recurrence of primary oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2017;21(3):461.
Article
Google Scholar
Ong HS, Gokavarapu S, Tian Z, Li J, Xu Q, Zhang CP, Cao W. PDGFRA mRNA overexpression is associated with regional metastasis and reduced survival in oral squamous cell carcinoma. J Oral Pathol Med. 2018;47(7):652–9.
Article
Google Scholar
Foy JP, Saintigny P, Goudot P, Schouman T, Bertolus C. The promising impact of molecular profiling on treatment strategies in oral cancers. J Stomatol Oral Maxillofac Surg. 2017;118(4):242–7.
Article
Google Scholar
Perrone F, Bossi P, Cortelazzi B, Locati L, Quattrone P, Pierotti MA, Pilotti S, Licitra L. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma. J Clin Oncol. 2010;28(5):761–6.
Article
Google Scholar
Qadir F, Lalli A, Dar HH, Hwang S, Aldehlawi H, Ma H, Dai H, Waseem A, Teh MT. Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma. BMC Cancer. 2019;19(1):830.
Article
Google Scholar
Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O’Sullivan B, Waldron J, Irish JC, et al. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Mol Cell Proteom. 2012;11(11):1404–15.
Article
Google Scholar
Mroz EA, Tward AD, Hammon RJ, Ren Y, Rocco JW. Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas. PLoS Med. 2015;12(2):e1001786.
Article
Google Scholar
Grewal JK, Tessier-Cloutier B, Jones M, Gakkhar S, Ma Y, Moore R, Mungall AJ, Zhao Y, Taylor MD, Gelmon K, et al. Application of a neural network whole transcriptome-based pan-cancer method for diagnosis of primary and metastatic cancers. JAMA Netw Open. 2019;2(4):e192597.
Article
Google Scholar
Li Y, Kang K, Krahn JM, Croutwater N, Lee K, Umbach DM, Li L. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data. BMC Genom. 2017;18(1):508.
Article
Google Scholar
Wang J, Wang Y, Kong F, Han R, Song W, Chen D, Bu L, Wang S, Yue J, Ma L. Identification of a six-gene prognostic signature for oral squamous cell carcinoma. J Cell Physiol. 2020;235(3):3056–68.
Article
Google Scholar
Zhao X, Sun S, Zeng X, Cui L. Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma. Am J Cancer Res. 2018;8(3):450–61.
PubMed
PubMed Central
Google Scholar
Huang GZ, Wu QQ, Zheng ZN, Shao TR, Lv XZ. Identification of candidate biomarkers and analysis of prognostic values in oral squamous cell carcinoma. Front Oncol. 2019;9:1054.
Article
Google Scholar
Lee DJ, Eun YG, Rho YS, Kim EH, Yim SY, Kang SH, Sohn BH, Kwon GH, Lee JS. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes. Oral Oncol. 2018;85:44–51.
Article
Google Scholar
Mostavi M, Chiu YC, Huang Y, Chen Y. Convolutional neural network models for cancer type prediction based on gene expression. BMC Med Genom. 2020;13(Suppl 5):44.
Article
Google Scholar
Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8–17.
Article
Google Scholar
Lyu B, Haque A. Deep learning based tumor type classification using gene expression data. bioRxiv 2018:364323.
Munir K, Elahi H, Ayub A, Frezza F, Rizzi A. Cancer diagnosis using deep learning: a bibliographic review. Cancers (Basel). 2019;11(9):1235.
Article
Google Scholar
Blundell C, Cornebise J, Kavukcuoglu K, Wierstra D. Weight-Uncertainty-in-neural-networks. In Proceedings of the 32nd international conference on machine learning 2015, 37.
Sainath TN, Kingsbury B, Saon G, Soltau H, Mohamed AR, Dahl G, Ramabhadran B. Deep convolutional neural networks for large-scale speech tasks. Neural Netw. 2015;64:39–48.
Article
Google Scholar
Zhang D-L, Qu L-W, Ma L, Zhou Y-C, Wang G-Z, Zhao X-C, Zhang C, Zhang Y-F, Wang M, Zhang M-Y, et al. Genome-wide identification of transcription factors that are critical to non-small cell lung cancer. Cancer Lett. 2018;434:132–43.
Article
Google Scholar
Wu H-T, Xie C-R, Lv J, Qi H-Q, Wang F, Zhang S, Fang Q-L, Wang F-Q, Lu Y-Y, Yin Z-Y. The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma. Lab Invest. 2018;98(8):1014–24.
Article
Google Scholar
Popescu NC, Goodison S. Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene. Mol Diagn Ther. 2014;18(3):293–302.
Article
Google Scholar
Fei L-R, Huang W-J, Wang Y, Lei L, Li Z-H, Zheng Y-W, Wang Z, Yang M-Q, Liu C-C, Xu H-T. PRDM16 functions as a suppressor of lung adenocarcinoma metastasis. J Exp Clin Cancer Res. 2019;38(1):35.
Article
Google Scholar